1-6 IDUSER RESPONDENT ID NUMBER 7-7 BIOSTAT SUMMARY OF BIOLOGICAL DATA COLLECTED 8-8 FLUSTAT SUMMARY OF FLU DATA COLLECTED 9-9 ALLOLOAD ALLOSTATIC LOAD SCORE (SUM OF ALLO1, ALLO2, ALLO3, ALLO4 ALLO5, ALLO6, ALLO7, ALLO8, ALLO9, ALLO10) 10-10 ALLO1 SYSTOLIC BLOOD PRESSURE GREATER THAN OR EQUAL TO 148? (PE1_9SA - BIO1DOC.TXT, COLUMNS 56-58) 11-11 ALLO2 DIASTOLIC BLOOD PRESSURE GREATER THAN OR EQUAL TO 83? (PE1.9DA - BIO1DOC.TXT, COLUMNS 44-46) 12-12 ALLO3 WAIST HIP RATIO GREATER THAN OR EQUAL TO 0.94? (WHRATIO AT COLUMN 20-25 BELOW) 13-13 ALLO4 TOTAL CHOLESTEROL/HDL CHOLESTEROL RATIO GREATER THAN OR EQUAL TO 5.9? (TOTHDL AT COLUMNS 26-31 BELOW) 14-14 ALLO5 GLYCOSYLATED HEMOGLOBIN GREATER THAN OR EQUAL TO 7.1? (LABHGBA1 AT COLUMNS 159-161 BELOW) 15-15 ALLO6 URINARY CORTISOL GREATER THAN OR EQUAL TO 25.7? (LABCORT2 AT COLUMNS 58-64 BELOW) 16-16 ALLO7 URINARY NOREPINEPHRINE GREATER THAN OR EQUAL TO 48? (NOREPI AT COLUMNS 44-50 BELOW) 17-17 ALLO8 URINARY EPINEPHRINE GREATER THAN OR EQUAL TO 5? (EPI AT COLUMNS 51-57 BELOW) 18-18 ALLO9 HDL CHOLESTEROL LESS THAN OR EQUAL TO 37? (LABHDLCH AT COLUMNS 133-135 BELOW) 19-19 ALLO10 DHEA-S LESS THAN OR EQUAL TO 35? (LABDHEAS AT COLUMNS 156-158 BELOW) 20-25 WHRATIO WAIST/ HIP RATIO (PE1.2/PE1.5 - BIO1DOC.TXT, COLUMNS 11-14 AND 22-25, RESPECTIVELY) 26-31 TOTHDL TOTAL CHOLESTEROL/HDL CHOLESTEROL RATIO (LABTCHOL/LABHDLCH - AT COLUMNS 130-132 & 133-135 RESPECTIVELY) 32-37 URCREAT URINE CREATININE (LABUCREA * 0.001 - AT COLUMNS 162-164) 38-43 URVOLDL URINE VOLUME (LABURVOL * 0.001 - AT COLUMNS 185-188) 44-50 NOREPI NOREPINEPHRINE ((LABNOREP/2)/(URCREAT * URVOLDL)) (SEE COLUMNS 165-169, 162-164, AND 38-43, RESPECTIVELY) 51-57 EPI EPINEPHRINE ((LABEPINE/2)/(URCREAT * URVOLDL)) (SEE COLUMNS 170-173, 162-164, AND 38-43, RESPECTIVELY) 58-64 LABCORT2 URINE CORTISOL LEVEL ADJUSTED FOR URINE CREATININE AND URINE VOLUME (LABCORUN COLUMN 184, LABCORTI COLUMNS 177-183, URCREAT COLUMNS 32-37, & URVOLDL COLUMNS 38-43. SEE ALLOSTATIC.TXT FOR COMPUTATION DETAILS) 65-65 HEMOLYZE HEMOGLOBIN PRESENT IN BLOOD PRIOR TO TESTING? 66-67 LABMO MONTH LAB TESTS WERE COMPLETED 68-69 LABDA DAY LAB TESTS COMPLETED 70-71 LABYR YEAR OF LAB TESTS COMPLETED 72-73 LABHEMAT HEMATOCRIT (VOLUME PERCENTAGE OF RED BLOOD CELLS IN WHOLE BLOOD) 74-77 LABHEMOG HEMOGLOBIN LEVEL 78-80 LABRCCNT RED BLOOD CELL COUNT 81-84 LABWCCNT WHITE BLOOD CELL COUNT 85-86 LABMCV MCV (MEAN CELL VOLUME) 87-88 LABMCHC MCHC (MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION) 89-92 LABRBCDW RED BLOOD CELL DISTRIBUTION, WIDTH 93-94 LABWESR WESTERGREN ESR (SEDIMENTATION RATE) 95-97 LABSODI SODIUM 98-100 LABPOTAS POTASSIUM 101-103 LABCHLOR CHLORIDE 104-105 LABCO2CO CARBON DIOXIDE (CO2) CONTENT 106-107 LABANION ANION GAP 108-110 LABGLUCO GLUCOSE 111-112 LABBUN BUN (BLOOD UREA NITROGEN) 113-115 LABCREAT BLOOD CREATININE 116-119 LABCALCI CALCIUM 120-122 LABMAGNE MAGNESIUM 123-125 LABPHOSP PHOSPHATE 126-129 LABUACID URIC ACID 130-132 LABTCHOL TOTAL CHOLESTEROL 133-135 LABHDLCH HDL CHOLESTEROL 136-138 LABTPROT TOTAL PROTEIN 139-141 LABALBUM ALBUMIN 142-144 LABTBILI TOTAL BILIRUBIN 145-147 LABGGTRA GG-TRANSPEPSIDASE (GAMMA GLUTAMYL) 148-150 LABALKPH ALKALINE PHOSPHATASE 151-152 LABAST AST (ASPARTATE AMINOTRANSFERASE) 153-155 LABTLD LDH, TOTAL (LACTATE DEHYDROGENASE) 156-158 LABDHEAS DHEA SULFATE (DEHYDROEPIANDROSTERONE) 159-161 LABHGBA1 HGB A1C (PERCENT GLYCATED HEMOGLOBIN A) 162-164 LABUCREA URINE CREATININE 165-169 LABNOREP NOREPINEPHRINE 170-173 LABEPINE EPINEPHRINE 174-176 LABDOPAM DOPAMINE 177-183 LABCORTI CORTISOL (SEE NOTE BELOW FOR UNITS) 184-184 LABCORUN CORTISOL UNITS 185-188 LABURVOL URINE VOLUME 189-192 LABURTIM URINE COLLECTION PERIOD 193-197 PSTPREAV RATIO OF THE AVERAGE 4 WEEK POST SAMPLE TO THE PRE VACCINATION SAMPLE FOR THE FIRST AND A SECOND ASSAYS, RESPECTIVELY. (PSTPREBA/PSTPRECD - BELOW) 198-202 PSTPREBA RATIO OF AVERAGE ANTIBODY RESPONSE FOR THE 4 WEEK POST VACCINATION BLOOD SAMPLE TO THE AVERAGE ANTIBODY RESPONSE FOR THE PRE VACCINATION BLOOD SAMPLE - FIRST RUN (ELAVGB/ELAVGA - BELOW) 203-207 PSTPRECD RATIO OF AVERAGE ANTIBODY RESPONSE FOR THE 4 WEEK POST VACCINATION BLOOD SAMPLE TO THE AVERAGE ANTIBODY RESPONSE FOR THE PRE VACCINATION BLOOD SAMPLE - SECOND RUN (ELAVGD/ELAVGC - BELOW) 208-212 ELAVGA AVERAGE ANTIBODY RESPONSE - PRE-VACCINATION BLOOD SAMPLE, FIRST RUN 213-217 ELAVGB AVERAGE ANTIBODY RESPONSE - 4 WEEK POST VACCINATION BLOOD SAMPLE, FIRST RUN 218-222 ELAVGC AVERAGE ANTIBODY RESPONSE - PRE VACCINATION BLOOD SAMPLE, SECOND RUN 223-227 ELAVGD AVERAGE ANTIBODY RESPONSE - 4 WEEK POST VACCINATION BLOOD SAMPLE, SECOND RUN 228-229 PRE1 ANTIBODY TITER FOR PRE-VACCINATION BLOOD DRAW, FIRST RUN IN 1997 230-232 POST1 ANTIBODY TITER FOR 4 WEEK POST VACCINATION BLOOD DRAW, FIRST RUN IN 1997 233-234 ABRISE INCREASE IN ANTIBODY TITER FROM PRE- VACCINATION BLOOD DRAW TO 4 WEEK POST VACCINATION BLOOD DRAW), FIRST RUN IN 1997 (PRE1/POST1) 235-236 PRE2 ANTIBODY TITER FOR PRE-VACCINATION BLOOD DRAW, SECOND RUN IN 1997 237-239 POST12 ANTIBODY TITER FOR 4 WEEK POST VACCINATION BLOOD DRAW, SECOND RUN IN 1997 240-241 ABRISE12 INCREASE IN ANTIBODY TITER FROM PRE- VACCINATION BLOOD DRAW TO 4 WEEK POST VACCINATION BLOOD DRAW), SECOND RUN IN 1997 (PRE2/POST2) 242-244 PRE98 ANTIBODY TITER FOR PRE-VACCINATION BLOOD DRAW IN 1998 245-247 POST198 ANTIBODY TITER FOR 2 WEEK POST VACCINATION BLOOD DRAW IN 1998 248-250 POST298 ANTIBODY TITER FOR 4 WEEK POST VACCINATION BLOOD DRAW IN 1998 251-253 POST398 ANTIBODY TITER FOR 6 MONTH POST VACCINATION BLOOD DRAW IN 1998 254-256 RISE198 INCREASE IN ANTIBODY TITER FROM PRE- VACCINATION BLOOD DRAW TO 2 WEEK POST VACCINATION BLOOD DRAW), IN 1998 (PRE98/POST198) 257-259 RISE298 INCREASE IN ANTIBODY TITER FROM PRE- VACCINATION BLOOD DRAW TO 4 WEEK POST VACCINATION BLOOD DRAW), IN 1998 (PRE98/POST298) 260-262 RISE398 INCREASE IN ANTIBODY TITER FROM PRE- VACCINATION BLOOD DRAW TO 6 MONTH POST VACCINATION BLOOD DRAW), IN 1998 (PRE98/POST398) 263-269 LAB1 CORTISOL LEVELS IN THE FIRST SALIVA SAMPLE COLLECTED AROUND THE MIDDLE OF THE EXPERIMENTAL SESSION. 270-276 LAB2 CORTISOL LEVELS IN THE SECOND SALIVA SAMPLE COLLECTED DURING THE EXPERIMENTAL SESSION, AFTER ALL THE PHYSIOLOGICAL ASSESSMENTS WERE COMPLETE. 277-283 DINNER CORTISOL LEVELS IN THE SALIVA SAMPLE COLLECTED AT THE GCRC JUST PRIOR TO EATING DINNER 284-290 BED CORTISOL LEVELS IN THE SALIVA SAMPLE COLLECTED AT THE GCRC JUST PRIOR TO BEDTIME 291-297 MORNING CORTISOL LEVELS IN THE SALIVA SAMPLE COLLECTED AT THE GCRC UPON WAKING IN THE MORNING 306-313 BASEFC7L BASELINE LATERALITY SCORE FOR FC8 (RIGHT) MINUS FC7 (LEFT) 314-321 PPREF3L LATERALITY SCORE JUST PRIOR TO WRITING ABOUT THE HIS OR HER MOST POSITIVE LIFE EXPERIENCE, FOR F4 (RIGHT) MINUS F3 (LEFT). 322-322 SORDER SLIDE SET OBSERVED (SAME SET OF SLIDES, RANDOMLY ORDERED IN 3 DIFFERENT WAYS) 323-323 EORDER ORDER IN WHICH RESPONDENT WROTE ABOUT SIGNIFICANT LIFE EVENTS (RANDOMLY DETERMINED) 324-330 EEBASE AVERAGE EYE BLINK MAGNITUDE DURING BASELINE EMOTION STARTLE PERIOD (PRIOR TO OBSERVING SLIDES OR COMPLETING WRITING TASK) 331-337 EEPOS AVERAGE EYE BLINK MAGNITUDE AFTER WRITING ABOUT THE MOST SIGNIFICANT POSITIVE LIFE EXERIENCE 338-344 EENEG AVERAGE EYE BLINK MAGNITUDE AFTER WRITING ABOUT THE MOST NEGATIVE LIFE EXPERIENCE 345-351 BASE BASELINE PROBES - INTER-TRIAL PROBES TO ASSESS RECOVERY BETWEEN TRIALS (THE PRESENTATION OF EACH SLIDE IS CONSIDERED A TRIAL) 352-358 POS AVERAGE EYE BLINK MAGNITUDE ACROSS 2.5 SECOND, 4.5 SECOND AND 7 SECOND PROBES IN CONJUNCTION WITH POSITIVE SLIDES 359-365 NEG AVERAGE EYE BLINK MAGNITUDE ACROSS 2.5 SECOND, 4.5 SECOND AND 7 SECOND PROBES IN CONJUNCTION WITH NEGATIVE SLIDES 366-372 NEUT AVERAGE EYE BLINK MAGNITUDE ACROSS 2.5 SECOND, 4.5 SECOND AND 7 SECOND PROBES IN CONJUNCTION WITH NEUTRAL SLIDES